Veritas Genetics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Veritas Genetics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10383
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Veritas Genetics Inc (Veritas Genetics) is a genome sequencing company that offers genomics testing and sequencing products and services. The company delivers actionable genetic insights to individuals and their doctors based on their DNA to manage their disease risk and plan their family health. Its products include myGenome, myBRCA, myBRCA HiRisk, myPrenatal, mycarrier, and myNewborn. Veritas Genetics’ myBRCA HiRisk is a multi-gene test to screen for hereditary breast and ovarian cancer risk. The company works with scientists, physicians, advisors, and patient advocates to design and deliver genetic testing solutions. It also has its presence in Shanghai and Hangzhou, China. Veritas Genetics is headquartered in Danvers, Massachusetts, the US.

Veritas Genetics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Veritas Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Veritas Genetics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Veritas Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Veritas Genetics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Veritas Genetics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Veritas Genetics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Veritas Genetics Raises USD1.7 Million in Venture Financing 10
Veritas Genetics Raises USD30 Million in Series B Financing 11
Veritas Genetics Raises USD10 Million in Series A Financing Round 12
Equity Offering 13
Veritas Genetics Raises USD9.6 Million in Financing 13
Acquisition 14
Veritas Genetics Acquires Curoverse 14
Veritas Genetics Inc – Key Competitors 15
Veritas Genetics Inc – Key Employees 16
Veritas Genetics Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Mar 28, 2018: Veritas Genetics Collaborates with Dr. Steven Narod and Women’s College Hospital to Launch The Screen Project – a Population-Based BRCA Screening Initiative across Canada 18
Corporate Communications 19
Jun 15, 2017: Veritas Genetics Welcomes Dr. Robert C. Green and Dr. Natasha Y. Frank to its Medical & Scientific Advisory Board 19
Feb 08, 2017: Globally Renowned Molecular Genetics Expert, Birgit Funke, PhD, Joins Veritas Genetics as Vice President of Clinical Affairs 20
Legal and Regulatory 21
Jun 01, 2018: Veritas Genetics China Passes CAP & CLIA Inspections for Next Generation Sequencing 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Veritas Genetics Inc, Medical Equipment, Key Facts 2
Veritas Genetics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Veritas Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Veritas Genetics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Veritas Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Veritas Genetics Inc, Deals By Market, 2012 to YTD 2018 8
Veritas Genetics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Veritas Genetics Raises USD1.7 Million in Venture Financing 10
Veritas Genetics Raises USD30 Million in Series B Financing 11
Veritas Genetics Raises USD10 Million in Series A Financing Round 12
Veritas Genetics Raises USD9.6 Million in Financing 13
Veritas Genetics Acquires Curoverse 14
Veritas Genetics Inc, Key Competitors 15
Veritas Genetics Inc, Key Employees 16
Veritas Genetics Inc, Other Locations 17
Veritas Genetics Inc, Subsidiaries 17

List of Figures
Veritas Genetics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Veritas Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Veritas Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Veritas Genetics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Veritas Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Veritas Genetics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Veritas Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Veritas Genetics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Veritas Genetics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vornado Realty Trust:企業のM&A・事業提携・投資動向
    Vornado Realty Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vornado Realty Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • The Mediterranean & Gulf Cooperative Insurance & Reinsurance Company (S.J.S.C):企業の戦略・SWOT・財務情報
    The Mediterranean & Gulf Cooperative Insurance & Reinsurance Company (S.J.S.C) - Strategy, SWOT and Corporate Finance Report Summary The Mediterranean & Gulf Cooperative Insurance & Reinsurance Company (S.J.S.C) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data …
  • MLM Biologics Inc:企業の製品パイプライン分析
    Summary MLM Biologics Inc (MLM Biologics) operates as a medical device company that provides optimum wound care management for patients and doctors. The company’s product includes bio-ConneKt Wound Matrix, a collagen-based wound dressing for chronic vascular ulcers, draining wounds, partial and full …
  • Ceres Nanosciences Inc:製品パイプライン分析
    Summary Ceres Nanosciences Inc (Ceres Nanosciences) is a provider of sample preparation products and diagnostic tests. The company offers Nanotrap particles for research and development and Nanotrap lyme antigen test that are protein enrichment toolset that can be integrated seamlessly into any exis …
  • IDT Corp (IDT):企業の財務・戦略的SWOT分析
    Summary IDT Corp (IDT) is a telecommunication service provider that offers mobile application development and telecommunication services. The company provides prepaid communication and payment services and international voice termination through its retail and wholesale division. Its services includ …
  • EDAP TMS SA (EDAP):医療機器:M&Aディール及び事業提携情報
    Summary EDAP TMS SA (EDAP) is a medical device company. It carries out the development, production and distribution of minimally invasive medical devices for the treatment of urological diseases. It offers High Intensity Focused Ultrasound (HIFU) devices for the treatment of localized prostate cance …
  • Schneider Electric SE (SU):石油・ガス:M&Aディール及び事業提携情報
    Summary Schneider Electric SE (Schneider Electric), formerly Schneider Electric SA, is an energy management and automation company that develops related technologies and solutions for electricity distribution. Its product line includes automation and control products, building management and securit …
  • Confluent Medical Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary Confluent Medical Technologies Inc (CMT), formerly Nitinol Devices and Components Inc is a medical device company that manufactures and markets nitinol devices and balloon catheters. The company’s products include wire, strip, sheet, tubing, and bar. Its development services include finite e …
  • The Dixie Group Inc:企業の戦略・SWOT・財務情報
    The Dixie Group Inc - Strategy, SWOT and Corporate Finance Report Summary The Dixie Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Standard Alliance Insurance Plc:企業の戦略・SWOT・財務分析
    Standard Alliance Insurance Plc - Strategy, SWOT and Corporate Finance Report Summary Standard Alliance Insurance Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • GSS Infotech Limited (GSS):企業の財務・戦略的SWOT分析
    GSS Infotech Limited (GSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Abu Dhabi Commercial Bank P.J.S.C.:戦略・SWOT・企業財務分析
    Abu Dhabi Commercial Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report Summary Abu Dhabi Commercial Bank P.J.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Caplin Point Laboratories Ltd (CAPLIPOINT):企業の財務・戦略的SWOT分析
    Summary Caplin Point Laboratories Ltd (Caplin Point) is a pharmaceutical company that manufactures creams, ointments, and other external application products. The company’s products in regulated market include opthalmic products, liquid injections and lyophilised injections. It also offers softgel c …
  • gel-e Inc:医療機器:M&Aディール及び事業提携情報
    Summary gel-e Inc (gel-e), formerly Remedium Technologies Inc, is a medical device company that provides products for the treatment of acute wounds. The company provides spray foams, bandages, gels, films, and band-aids. It provides proprietary technology platform that helps develop wound treatment …
  • Nampak Limited:企業の戦略・SWOT・財務情報
    Nampak Limited - Strategy, SWOT and Corporate Finance Report Summary Nampak Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Cox & Kings Limited
    Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report Summary Cox & Kings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Grifols SA (GRF):企業の財務・戦略的SWOT分析
    Grifols SA (GRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • PT Pertamina (Persero):石油・ガス:M&Aディール及び事業提携情報
    Summary PT Pertamina (Persero) (Pertamina) is a state-owned integrated energy company. It has operations across the energy value chain from upstream to downstream. Its upstream operations include exploration, development and production of oil and natural gas. The company also provides upstream techn …
  • Flynn Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Flynn Pharma Ltd (Flynn Pharma) is a pharmaceutical company that manufactures and markets barbiturate products, and oral and injectable antibiotics. The company’s products include cefuroxime, circadin, distaclor, keflex, medikinet tablets, medikinet XL capsules, nebcin, nizatidine, phenytoin …
  • The Shipping Corporation of India Ltd (SCI):企業の財務・戦略的SWOT分析
    The Shipping Corporation of India Ltd (SCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆